The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer by Schulkes, K.J.G. et al.
Vol.:(0123456789) 
Lung (2017) 195:225–231 
DOI 10.1007/s00408-017-9983-7
The Effect of A Geriatric Assessment on Treatment Decisions 
for Patients with Lung Cancer
Karlijn J. G. Schulkes1 · Esteban T. D. Souwer2 · Marije E. Hamaker3 · 
Henk Codrington4 · Simone van der Sar-van der Brugge5 · Jan-Willem J. Lammers6 · 
Johanneke E. A. Portielje2 · Leontine J. R. van Elden7 · Frederiek van den Bos2 
Received: 1 December 2016 / Accepted: 4 February 2017 / Published online: 9 March 2017 
© The Author(s) 2017. This article is published with open access at Springerlink.com
with a curative intent. Half of the patients were classified 
as ECOG PS 0 or 1. The majority of the patients (78%) 
suffered from geriatric impairments and 43% (n = 35) of 
the patients suffered from three or more geriatric impair-
ments (out of eight analyzed domains). Nutritional status 
was most frequently impaired (52%). Previously undiag-
nosed impairments were identified in 58% of the patients, 
and non-oncologic interventions were advised for 43%. 
For 33% of patients, adaptations of the oncologic treatment 
were proposed. Patients with higher number of geriatric 
impairments more often were advised a reduced or less 
intensive treatment (p < 0.001).
Conclusion A geriatric assessment uncovers previously 
unknown health impairments and provides important guid-
ance for tailored treatment decisions in patients with lung 
Abstract 
Background Decision-making for older patients with 
lung cancer can be complex and challenging. A geriatric 
assessment (GA) may be helpful and is increasingly being 
used since 2005 when SIOG advised to incorporate this in 
standard work-up for the elderly with cancer. Our aim was 
to evaluate the value of a geriatric assessment in decision-
making for patients with lung cancer.
Methods Between January 2014 and April 2016, data on 
patients with lung cancer from two teaching hospitals in the 
Netherlands were entered in a prospective database. Out-
come of geriatric assessment, non-oncologic interventions, 
and suggested adaptations of oncologic treatment proposals 
were evaluated.
Results 83 patients (median age 79 years) were analyzed 
with a geriatric assessment, of which 59% were treated 
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cancer. More research on GA-stratified treatment decisions 
is needed.
Keywords CGA · Frailty · Geriatric assessment · 
Pulmonary malignancies
Abbreviations
BSC  Best supportive care
CCI  Charlson comorbidity index
G8  Geriatric 8
(I)ADL  (Instrumental) Activities of daily living
ISAR-HP  Identification of seniors at risk-hospitalized 
patients
NSCLC  Non-small cell lung cancer
PS  Eastern Cooperative Oncology Group Perfor-
mance Status
SCLC  Small cell lung cancer
SBRT  Stereotactic body radiotherapy
SIOG  International Society of Geriatric Oncology
Introduction
In the Netherlands, over 12,000 new cases of lung cancer 
are diagnosed every year [1]. Lung cancer is predominantly 
a disease of the elderly: half of all newly diagnosed patients 
are over 70 years old [1]. Lung cancer usually shows an 
aggressive course of disease, and mortality rates are high. 
It is the leading course of cancer mortality worldwide [2]. 
Survival rates are even worse in elderly patients (>75), 
with 1 and 5 year survival rates of 33 and 10%, respectively 
[1].
Older patients represent a heterogeneous population 
due to differences in physiological reserves, comorbidity, 
functional capacity, and the presence of geriatric impair-
ments [3]. As a result of these differences, benefit from 
lung cancer treatment varies [4–6]. In addition, complica-
tions of therapy are common and are more likely to occur 
in patients with decreased physiological reserves [7].
Currently used measures for quantifying health status 
and reserves in patients with lung cancer, such as perfor-
mance status or pulmonary function testing, do not appear 
to differentiate sufficiently within the elderly population 
[3]. Even in patients with good performance status, geri-
atric impairments can be present because impairments in 
cognitive functioning, depressive symptoms, and malnutri-
tion are easy to miss [7–9].
Therefore, in 2005, a task force of the International 
Society of Geriatric Oncology (SIOG) recommended that 
a geriatric assessment should be used to detect these unad-
dressed problems, improve functional status, and possi-
bly survival [3]. This systematic procedure can be used to 
objectively appraise the health status, focusing on somatic, 
functional, and psychosocial domains [3, 10].
Although a myriad of publications have propagated its 
use, the actual implementation of geriatric assessments in 
clinical practice has thus far been limited [3, 11–13]. In 
the Diakonessenhuis and Haga hospital, two large teach-
ing hospitals in the Netherlands, geriatric assessments for 
patients with lung cancer have been implemented in the 
standard care for patients over 70 years of age since 2014. 
In this analysis, we have assessed the yield of this assess-
ment and its effect on treatment decisions.
Methods
Between January 2014 and April 2016, all consecutive 
patients with lung cancer aged 70 years and older referred 
for a geriatric assessment at the Haga hospital in the Hague 
were included in a prospective database for quality con-
trol purposes. No patients were excluded for this initial 
database. Selection of patients for a geriatric assessment 
was done if the patient was considered to be potentially 
frail based on the Geriatric8 (G8) [14] and identification 
of seniors at risk (ISAR-HP) [15] screening tools or by 
the referring physician/thoracic oncologist based on clini-
cal judgment. The maximum score of the G8 is 17 points, 
with a score of 14 or less being defined as impaired [14]. 
The maximum score of the ISAR-HP is 4, and a score of 2 
or more is defined as impaired [15]. Oncologic treatment 
options were formulated by the thoracic oncologist, based 
on a complete oncologic work-up, prior to referral for the 
geriatric assessment.
The geriatric consultations and assessments were per-
formed by three geriatricians specialized in geriatric oncol-
ogy. Patients were seen together with their family or car-
egivers if possible. The geriatric assessment was partly 
performed by a specialized nurse and included an evalu-
ation across eight geriatric domains: comorbid diseases, 
medication use, diagnosis and, if applicable, treatment of 
cognitive impairments, mood disorders, nutritional status, 
functional impairments (mobility, basic, and (instrumen-
tal) activities of daily living ((I)ADL)), and social network 
or supportive care status. Specific geriatric tools per geri-
atric domain were used on indication: Charlson Comor-
bidity Index [16] to score comorbidity (a score of ≥2 was 
defined as impaired), medication use was defined as an 
impaired geriatric domain if patients used three or more 
drugs or in case of inappropriate prescription, mini nutri-
tional assessment (maximum 27 points, impaired ≤ 23) 
[17], mini mental state examination (maximum 30 points, 
impaired ≤ 23.5) [18], geriatric depression scale (maxi-
mum 15 points, possible depression ≥6) [19], timed-up-
and-go-test (impaired ≥ 12  s) [20, 21], hand grip strength 
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(age-related cutoff values, no adjustment from the original 
research) [22], Katz index (six items scored, impaired ≥ 2) 
[23], and Lawton (maximum 8 points, 0 indicating fully 
dependency, impaired ≥ 2) [24] were used for scoring ADL 
en IADL, respectively. The geriatrician interpreted the 
assessment outcomes, reflected on them with patient and 
caregivers, proposed interventions for optimization impair-
ments that were found, and discussed the patients’ prefer-
ences and expectations.
Based on this assessment and consultation, the geri-
atrician evaluated the patient’s capacity to tolerate treat-
ment within the multidisciplinary lung cancer team and 
if needed, proposed an adaptation of oncologic treatment, 
tailored to the patient’s capacities, health limitations, and 
preferences. If applicable, advanced care planning was 
initiated.
The treatment adaptations were labeled as ‘no change’ 
if the geriatrician agreed with the treatment plan of the 
oncologist. If the geriatrician advised for a different regi-
men than suggested by the oncologist, these changes were 
categorized as ‘more intensive’ or ‘less intensive.’
Data Collection
The regional ethics committee and institutional review 
board of both hospitals approved this study. The primary 
endpoint was the effect of the geriatric assessment on 
(adaptation of) oncologic and non-oncologic treatment 
decisions. Secondary endpoints were the prevalence of ger-
iatric impairments, the incidence of newly diagnosed geri-
atric syndromes or medical conditions, and the additional 
yield of the assessment in terms of advanced care planning, 
managing the patients’ expectations, and clarifying the 
patients’ priorities and preferences.
The following data were collected from the medical 
record: patient demographics (age, sex, Eastern Coopera-
tive Oncology Group Performance Status (PS) [25], comor-
bidity measured by the Charlson comorbidity index (CCI) 
[16]), tumor data (tumor type, staging), initial oncologic 
treatment plan and alternative options prior to geriatric 
assessment, final oncologic treatment following geriatric 
assessment. In addition, we collected information on out-
come of the geriatric assessment: prevalence of geriatric 
impairments, incidence of newly diagnosed medical condi-
tions, non-oncologic interventions, suggestions regarding 
oncologic treatment choices, discussions on advanced care 
planning, clarification of patients’ priorities, and expecta-
tions regarding oncologic treatment.
Statistical Analysis
For the analysis of our primary outcome, treatment deci-
sions following geriatric assessment were classified as 
follows: no change, intensified oncologic treatment, less 
intensive treatment, or supportive care only. Numbers are 
presented as medians with interquartile ranges (IQR) if 
not normally distributed. Statistical analyses were per-
formed using SPSS 24.0 (SPSS, Inc., Chicago, IL, USA). 
A p value <0.05 was considered statistically significant. 




Eighty-three patients were included in the present analy-
sis. Patient demographics can be found in Table  1. The 
median age of the patients was 79 years (IQR 74–82 
years) and 65% were male (n = 54). The CCI was 0 or 1 
for 23 patients (28%), the remaining 73% (n = 60) had a 
CCI of 2 or higher. The majority of the patients (n = 49, 
59%) were diagnosed with non-small cell lung cancer 
Table 1  Patient characteristics
a IQR25-75 Interquartile ranges 25th and 75th percentile
b ECOG PS Eastern Cooperative Oncology Group Performance Status
c (N)SCLC non-small cell lung cancer
Total (n = 83)
Male (%) 54 (65)







No histological diagnosis 23 (28)










0 or 1 23 (28)
≥2 60 (72)
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(NSCLC), nine patients (11%) were diagnosed with small 
cell lung cancer (SCLC), two patients (2%) were diag-
nosed with mesothelioma, and for 23 patients (28%) no 
histological diagnosis was obtained. Most patients had 
options for treatment with a curative intent (n = 49, 59%), 
for the remaining patients the treatment intent was only 
palliative at time of diagnosis and assessment. For 25 
patients (30%) the PS was unknown; of the remaining 
patients 42 were (72%) classified as PS 0 or 1; 11 (19%) 
patients had a PS of two; and five (9%) patients had a PS 
of three.
Geriatric Assessment
The majority of the patients (n = 66, 80%) were referred for 
a geriatric assessment after risk identification by using Ger-
iatric8 (G8 ≤ 14) or identification of seniors at risk (ISAR-
HP ≥ 2), and the remaining 17 patients (20%) were referred 
by the treating physician based on clinical judgment. For 
all patients, the GA was performed prior to initiation of 
oncologic treatment.
Results of geriatric assessments are depicted in Table 2. 
The majority of the patients (78%; n = 65) suffered from 
one or more geriatric impairments: in 43% (n = 35) ≥3 ger-
iatric impairments were identified. Nutritional status was 
most frequently impaired (52%; n = 43), followed by mobil-
ity (39%; n = 32) and cognitive function (34%; n = 28). 
For 58% of the patients (n = 48), the geriatric assessment 
revealed previously unknown geriatric impairments. Non-
oncologic interventions aimed to optimize health status 
before and during cancer treatment were proposed for 36 
patients (43%). Domains that were most frequently amena-
ble for intervention were nutritional status (25%; n = 21), 
followed by impaired mobility based on an impaired timed-
up-and-go or low handgrip strength (14%; n  = 12) and care 
dependency in IADL (10%; n  =  8). A total of five patients 
had an impaired GDS and three were subsequently referred 
for further counseling. Other suggested non-oncologic 
interventions are described in detail in the Appendix 1 [26].
In addition, for 69% (n = 57) of patients, the geriatric 
assessment aided in clarifying patients preferences and 
expectations or initiating advance care planning.
Treatment Decisions
Based on the geriatric assessment, suggestions for change 
of the oncologic treatment were proposed in 27 out of 83 
patients (33%); the thoracic oncologists adopted all sug-
gestions. These results are shown in Fig. 1 and Appendix 
2. A more intensive treatment regimen was suggested for 
one patient (1%): the geriatrician advised for stereotactic 
radiotherapy (SBRT) instead of the suggested best support-
ive care (BSC) of the oncologist. A less intensive treatment 
regimen was suggested for twenty-six patients (31%). A 
less intensive treatment suggestion included SBRT instead 
of surgical resection (n = 6) or BSC instead of palliative 
chemotherapy (n = 11), chemoradiotherapy (n = 5), or sur-
gical resection (n = 4).
We did not find a significant difference in change of 
treatment based on the geriatric assessment between 
patients treated with a palliative or curative intent.
For patients with a higher number of geriatric impair-
ments, more often an adapted treatment plan was advised: 
a less intensive treatment was suggested for 13% of patients 
(n = 6) with ≤2 geriatric impairments versus 57% (n = 20) 
for the patients with >2 geriatric impairments (p < 0.001).
No significant difference could be observed by analyz-
ing treatment decisions comparing different age categories 
(<75, 75–80 and older than 80 years) (p = 0.56).
Discussion
This study shows the results of geriatric assessments and 
consultations in patients with lung cancer in two teaching 
hospitals in the Netherlands. The prevalence and num-
ber of geriatric impairments was high in the investigated 
elderly population (78%), especially considering that half 
of the patients had an ECOG PS of 0 or 1. The geriat-
ric assessment identified previously undiagnosed impair-
ments in 58% of the patients and non-oncologic inter-
ventions were advised for 43%. Nutritional status was 
most frequently impaired, followed by impairments in 
mobility and cognitive function. For 34% of the patients, 
adaptations in the oncologic treatment were suggested 
after the geriatric assessment. With increasing numbers 
of observed geriatric impairments, less aggressive treat-
ment was more often advised. In addition, the geriatric 
Table 2  Outcome of geriatric assessment
a (I)ADL (Instrumental) activities of daily living
b Impaired score on geriatric depression scale





(Risk of) malnutrition 43 (52%) 21 (25%)
Impaired mobility 32 (39%) 12 (15%)
Cognitive impairments 28 (34%) 6 (7%)
Care dependence in  IADLa 26 (31%) 8 (10%)
Comorbidity 26 (31%) 4 (5%)
Insufficient social network 20 (24%) 6 (7%)
Care dependence in  ADLa 17 6 (7%)
Medication issues 9 (11%) 1 (1%)
Psychological  issuesb 5 (6%) 3 (7%)
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assessment was often used as a moment to start discus-
sions about preferences and expectations of treatment or 
initiating advance care planning.
This analysis has several limitations. First, in this 
type of observational cohort study, a direct comparison 
of survival and oncologic outcomes between groups is 
hampered by selection bias and confounding by indica-
tion. This could subsequently mean that differences in 
outcome are incorrectly attributed to the treatment deci-
sion, rather than to confounding factors such as poor 
general health, which affects both treatment choice and 
outcome. We have no data on health status or treatment 
decisions in older patients who were not referred. Sec-
ond, we only reported on the alteration in treatment, 
but limited data were available about follow-up of how 
patients subsequently fared. Furthermore, as no control 
group was available, we were unable to ascertain whether 
the changes made for the treatment plan resulted in over-
all better outcomes. Despite these limitations, this anal-
ysis provides insight in current clinical practice and the 
variety of elderly patients with lung cancer that are being 
referred for a geriatric assessment.
Our findings are in line with prior research that empha-
sized the importance of a geriatric assessment in the care 
of elderly patients with cancer [3, 10]. A study among 49 
patients with lung cancer in France also showed a high 
number (45%) of modifications of treatment decisions after 
a geriatric assessment [27]. Another study, performed in 
Belgium reported the presence of one or more geriatric 
impairments in 71% of patients with lung cancer [28]. In a 
Dutch study among patients with various cancer types, pre-
viously undiagnosed impairments were identified in 49% 
and non-oncologic interventions were initiated in 56% [29].
Our study demonstrates that geriatric assessment can be 
helpful in the complex decision-making process for elderly 
patients with lung cancer. Decisions in this heterogeneous 
population can be complex, particularly because evidence 
regarding treatment of frail patients is scarce as the patients 
are frequently excluded from participation in clinical tri-
als [30]. As was previously demonstrated, study results are 
primarily valid within a population that is comparable to 
the trial population and do not provide reliable evidence 
on what the effect would be in other patient groups [31]. 
As a result, treatment decisions for the elderly will mainly 
depend on opinions and preconceptions of individual 
oncologists.
The effect of GA-stratified treatment allocation has not 
been extensively investigated. A GA-stratified treatment 
allocation in patients with lung cancer did not improve 
efficacy but showed comparable survival and appeared to 
be able to decrease overall toxicity and aggressiveness of 
treatment [32]. Experiencing less all grade toxicity and 
receiving less aggressive treatment without losing efficacy 
can be seen as an important argument to advocate treat-
ment allocation on the basis of a geriatric assessment. More 
research is urgently needed to further extent these findings.
The incorporation of a routine geriatric assessment in 
standard oncologic care for all elderly patients with cancer 
Fig. 1  Oncologic treatment suggestions based on geriatric assess-
ment. Less intensive the geriatrician advised for a less intensive treat-
ment than suggested by the oncologist, More intensive the geriatrician 
advised for a more intensive treatment than suggested by the oncolo-
gist, No change after GA there was no difference in oncologic treat-
ment after the geriatric assessment
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is currently hampered by the time- and resource-consuming 
nature of these assessments [12, 13]. Furthermore, while 
there is general consensus that they can be beneficial, there 
is no clear guideline on when, how, and by whom they 
should be performed [12, 13]. The presented method of 
geriatric screening followed by full geriatric consultation 
and assessment for selected patients may be adequately 
time efficient. Importantly, it is still a matter of debate 
whether cancer specialists themselves should take more 
time to assess patients across multiple (geriatric) domains 
instead of introducing geriatric consultation by a geriatri-
cian into the care pathway of older patients with cancer, 
keeping in mind that the latter requires geriatricians with 
specific expertise in oncology.
An important yield of the geriatric assessment was clari-
fying patient’s priorities and expectations concerning the 
proposed treatment options. It appears that this is mostly 
due to a greater amount of time available for the assessment 
and does not necessarily require expertise specific to the 
geriatrician [13]. In an age where the amount of time spent 
on staging and exploring disease characteristics is rapidly 
increasing, and more and more money is spent on increas-
ingly sophisticated anti-cancer treatments, taking the time 
to sit down with a patient and explore what they want and 
whether or not they will be able to benefit from and tolerate 
cancer treatment should not be a matter of discussion [33]. 
However, this will require the incorporation of more elabo-
rate training in the specific needs of frail elderly patients in 
oncologic study curricula.
Conclusion
This analysis shows that a geriatric assessment can aid in 
tailoring treatment decisions, by identifying previously 
unknown geriatric impairments. Our findings are in line 
with the SIOG advise that a geriatric assessment should be 
used in the evaluation of elderly patients with cancer [11]. 
There is a significant relation between the number of geri-
atric impairments and the advice for less aggressive treat-
ment. A geriatric assessment is often used as moment to 
start discussions about preferences and expectations of 
treatment. Collaboration between geriatricians and oncolo-
gists is required to optimize treatment for patients with 
cancer [29]. More research on GA-stratified treatment deci-
sions in patients with lung cancer is needed.
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Table 3  Examples of suggested 
non-oncologic interventions
a (I)ADL (Instrumental) activities of daily living
Examples of suggested non-oncologic interventions [26]
(Risk of) malnutrition Referral to dietician, supplemental nutrition drinks
Impaired mobility Home care, referral occupational therapist, physiotherapist
Cognitive impairments Home care, start medication, update medication list, referral 
to specialized nurses
Care dependence in (I)ADLa Home care, occupational therapist, physical therapist
Comorbidity Update medication list, diagnose and treat comorbidities
Insufficient social network Home care, specialized nurses, consulting general practitioner
Medication issues Update medication list
Psychological issues Referral to general practitioner, referral to psychologist
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